STEVENS CAPITAL MANAGEMENT LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 121 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.5%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$201,000
-18.3%
8,142
-49.5%
0.01%
-20.0%
Q1 2016$246,000
-74.5%
16,135
-77.5%
0.01%
-73.7%
Q4 2015$963,000
+59.4%
71,618
+66.3%
0.04%
+35.7%
Q3 2015$604,000
+141.6%
43,055
+43.0%
0.03%
+250.0%
Q4 2014$250,000
-15.3%
30,115
-8.6%
0.01%0.0%
Q1 2014$295,00032,9480.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders